DNMT3A and TET2 are also candidate genes for CHIP mutations, as loss-of-function mutations in these genes are commonly detected in the peripheral blood samples of patients with myelodysplastic syndromes and acute myeloid leukemia (8). This evidence concerns the gene STUB1 and acute myeloid leukemia.